Clinical Trial Update: Use of Formula Fortified With DHA in Infants With Cystic Fibrosis [NA]

View source ↗

Summary

A completed clinical trial evaluated an infant formula fortified with DHA for infants with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• DHA-fortified infant formula (docosahexaenoic acid fortified infant formula)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Cystic Fibrosis | NA | Status: COMPLETED